Top Suppliers:I want be here
Related CAS#:
925920-88-3 1207052-26-3
1158522-08-7 940364-43-2
134104-43-1 131615-57-1
951937-01-2 6906-52-1
930439-75-1 1018584-77-4

874902-19-9

874902-19-9 structure
874902-19-9 structure
  • Name: LY2183240
  • Chemical Name: N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide
  • CAS Number: 874902-19-9
  • Molecular Formula: C17H17N5O
  • Molecular Weight: 307.350
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease FAAH
  • Create Date: 2018-12-31 12:47:06
  • Modify Date: 2024-01-31 17:34:31
  • LY2183240 is a novel and highly potent blocker of anandamide uptake (IC50 = 270 pM). LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). IC50: 270 pM (anandamide uptake); 12.4 nM (FAAH)Target: FAAH; Anandamide uptakeFollowing i.p. administration in rats, LY2183240 increases brain anandamide concentration and exerts antinociceptive effects in formalin model of pain.
Name N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide
Synonyms 5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
LY-2183240
HMS3269E15
1H-Tetrazole-1-carboxamide
1H-Tetrazole-1-carboxamide, 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-
5-(Biphenyl-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
LY2183240
Description LY2183240 is a novel and highly potent blocker of anandamide uptake (IC50 = 270 pM). LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). IC50: 270 pM (anandamide uptake); 12.4 nM (FAAH)Target: FAAH; Anandamide uptakeFollowing i.p. administration in rats, LY2183240 increases brain anandamide concentration and exerts antinociceptive effects in formalin model of pain.
Related Catalog
References

[1]. Dickason-Chesterfield AK, et al. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23.

[2]. Alexander JP, Cravatt BF. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J Am Chem Soc. 2006 Aug 2;128(30):9699-704.

[3]. Maione S, et al. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. Br J Pharmacol. 2008 Nov;155(5):775-82.

[4]. Pelorosso FG, et al. The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein. Eur J Pharmacol. 2009 Jan 5;602(1):176-9.

[5]. Powers MS, et al. Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference. Psychopharmacology (Berl). 2010 Dec;212(4):571-83.

[6]. Sun L, et al. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation. Eur J Pain. 2017 May;21(5):804-814.
Density 1.2±0.1 g/cm3
Boiling Point 506.1±53.0 °C at 760 mmHg
Melting Point 87-88ºC
Molecular Formula C17H17N5O
Molecular Weight 307.350
Flash Point 259.9±30.9 °C
Exact Mass 307.143311
PSA 63.91000
LogP 2.15
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.640
Storage condition 2-8℃
Risk Phrases 22

Chemsrc provides CAS#:874902-19-9 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 874902-19-9 | Chemsrc address: https://www.chemsrc.com/en/baike/1104890.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved